05Jun
What We Learned From FDA's Public Hearing On Cannabis
The much-anticipated public hearing last week at the U.S. Food and Drug Administration on cannabis and cannabis-derived compounds drew a wide audience of participants, with strong views on how the FDA should (or should not) regulate the controversial...
By:
Sheppard Mullin Richter & Hampton LLP
Related
The United States Department of Labor today released new regulations that dramatically change the ex...
Read More >
The 2017 Tax Cuts and Jobs Act (the “TCJA”) eliminated the 50% deduction for any expenses related ...
Read More >
The National Labor Relations Board (NLRB) recently issued a decision in employers’ favor by holding...
Read More >
To many employees, being written up is perceived as another way of being told that someone is the bo...
Read More >
Overruling Banner Estrella Medical Center, 362 NLRB 1108 (2015), the National Labor Relations Board ...
Read More >
On June 19, 2019, the New York State Assembly passed sweeping legislation designed to increase prote...
Read More >